A $936 million health agreement with Malawi shows what replaced U.S. foreign aid
Washington intends to provide up to $792 million over five years. Malawi commits the rest — and the money is meant to flow through the government rather than NGOs.
The United States and Malawi signed a five-year, $936 million bilateral health cooperation Memorandum of Understanding on January 14 [s1]. The number is large enough to lead the announcement, but the architecture underneath it is the part worth reading closely, because it is the template the State Department says it intends to replicate.
The arithmetic
Under the arrangement, and working with Congress, the United States intends to provide up to $792 million over the next five years to support Malawi's efforts against HIV/AIDS, malaria, and other infectious diseases, and to bolster disease surveillance and outbreak response [s1]. Malawi, for its part, will increase its overall annual health spending by an additional $143.8 million during the life of the MOU [s1].
Those two figures together produce the headline total. That is the first structural point: the $936 million is not a U.S. commitment. It is a combined commitment, in which the United States intends up to $792 million and Malawi supplies $143.8 million [s1].
The State Department describes the MOU as covering a comprehensive range of health priorities in which Malawi will co-invest — HIV/AIDS, tuberculosis, malaria, maternal and child health, polio, and global health security — while supporting solutions such as digitalisation to reach rural populations [s1].
The delivery change
The second structural point is about who handles the money. The announcement states that the MOU "marks a critical shift away from parallel NGO delivery systems and the healthcare workforce structures they created, restoring responsibility for those resources to the national government" [s1].
That sentence describes the dismantling of a delivery model in which U.S. programs contracted implementing partners — international and local non-governmental organisations — that hired clinical staff and ran service sites. The State Department's own characterisation is that those partners created healthcare workforce structures parallel to the national system, and that the MOU restores responsibility for those resources to the government [s1].
Moving that responsibility to a health ministry is a coherent policy position with a real argument behind it: parallel systems can distort domestic labour markets, and a program that cannot be absorbed by the government does not survive the donor's departure. It is also a substantial operational risk in the short term, because absorption capacity is not created by an agreement.
The announcement does not address transition mechanics — how staff currently employed by implementing partners move, over what period, or what happens to service continuity during the handover. The MOU text itself was not published alongside the statement.
The strategy it implements
The MOU is an instrument of the America First Global Health Strategy, which the State Department describes as protecting the homeland by preventing infectious disease outbreaks from reaching U.S. shores, strengthening bilateral relationships through multi-year agreements that require co-investment from recipient governments, and promoting American health innovation abroad [s2].
The framing in the Malawi statement follows that logic closely: a model of assistance "that prioritizes the protection of the American people from infectious disease threats while empowering recipient countries to achieve self-reliance and accountability within their national healthcare systems" [s1].
Malawi is presented as a case where this is plausible. The announcement says the MOU is designed to leverage the country's progress against HIV/AIDS and to support its commitment to maintaining its 95-95-95 goals for epidemic control through sustainable, integrated service delivery that the government will self-maintain after the MOU concludes [s1].
That last clause states the exit condition plainly. The agreement is designed to end.
What is not yet knowable
Several things that determine whether this works are absent from the record as of mid-January.
Whether the money arrives. The U.S. contribution is framed as an intention, contingent on working with Congress [s1]. An MOU is not an appropriation.
Whether $143.8 million is annual or cumulative. The statement says Malawi will increase overall annual health spending "by an additional $143.8 million during the life of the MOU," which is compatible with more than one reading [s1]. The distinction is material to whether the co-investment requirement is achievable.
How the year-by-year profile is shaped. Multi-year totals conceal timing. Whether U.S. support is level, front-loaded, or declining across the five years determines how much domestic capacity has to be stood up, and how fast.
Whether service delivery holds during the transition. This is the empirical question that matters most for people in Malawi receiving antiretroviral therapy, malaria treatment, or antenatal care, and it will only be answerable from program data over the coming years.
What to watch
The State Department says it remains committed to signing multi-year bilateral global health MOUs "in the coming weeks with dozens of countries" receiving U.S. health assistance [s1]. Each will presumably carry its own co-investment ratio and its own transition timetable.
The useful comparison, once several are public, will not be the headline totals. It will be the ratio of U.S. money to recipient-government money, the year-by-year shape of the U.S. contribution, and whether the agreements name the diseases that account for the local burden of death rather than the ones that travel.
Sources
- Driving Progress on the America First Global Health Strategy Through Bilateral Global Health MOU with Malawi — U.S. Department of State, Office of the Spokesperson , January 14, 2026
- America First Global Health Strategy — U.S. Department of State , September 18, 2025
More on
Global health aid is on track for $38.4bn this year, a level last seen in 2009
IHME's annual accounting puts development assistance for health at less than half its 2021 peak, with no recovery forecast to 2030. A companion model estimates what that means for tuberculosis.
HIV, TB and malaria programs saved health systems $135 billion in avoided visits
The estimate covers 2000 to 2023 and 108 countries. It is a counterfactual model, not a measured saving, and it lands as the US and other donors debate cutting the disease-specific funding it credits.
The first hard numbers on what the PEPFAR stop-work orders did to HIV services
Across 165 clinics in four African countries, HIV testing fell by up to 35% and treatment starts by up to 32%. Most services had not returned to baseline two months after the orders were lifted.
A modelling study puts 9.4 million deaths on the mild aid-cut scenario, not the severe one
The Lancet Global Health paper that produced this month's headline number also produced a larger one: 22.6 million additional deaths by 2030 if defunding deepens. The distinction matters more than the figure.